PharmaCielo Ltd.
PCLO.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 60.48% | 50.53% | 54.68% | 46.27% | 41.64% |
| Total Depreciation and Amortization | 7.30% | -2.65% | -24.18% | -17.52% | 7.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -111.60% | -43.60% | -52.30% | -40.08% | -24.92% |
| Change in Net Operating Assets | -323.96% | -197.38% | -113.65% | 59.68% | -70.76% |
| Cash from Operations | -173.73% | 31.67% | 37.99% | 129.65% | 62.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -24.92% | -69.30% | -80.56% | -85.63% |
| Cash from Investing | 31,569.00% | 15,840.66% | 7,541.16% | -79.82% | -85.43% |
| Total Debt Issued | -82.62% | -69.32% | -70.15% | -56.88% | -46.70% |
| Total Debt Repaid | -688.34% | -731.22% | -629.06% | -206.29% | 7.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -432.02% | -385.87% | -271.88% | -130.32% | -59.04% |
| Foreign Exchange rate Adjustments | 1,050.00% | 546.15% | 66.22% | -78.38% | -102.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -232.00% | 201.13% | 11,290.91% | 222.34% | 96.47% |